Christof Simon, Author at DC-ren

For the public & patients Physicians & academics

December 31, 2023

DC-ren project status

The second periodic report is completed and DC-ren met all major project milestones.

Christof Simon

Love0

The DC-ren state map concept.

For the public & patients Physicians & academics

December 29, 2023

Context and overall objectives of the project.

Diabetic Kidney Disease (DKD) is a serious clinical condition, and the incidence increases in parallel…

Christof Simon

Love0

For the public & patients

December 22, 2023

Drug combinatinos for re-writing trajectories of renal pathologies in type II diabetes

Christof Simon

Love0

For the public & patients

December 22, 2023

Big data and precision medicine

Christof Simon

Love0

Industry & stakeholders Physicians & academics

December 14, 2023

DC-ren associated studies

The concept of precision medicine as proposed by DC-ren is also of great interest to…

Christof Simon

Love0

Physicians & academics

November 29, 2023

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease.

Ahluwalia TS, Rönkkö TKE, Eickhoff MK, Curovic VR, Siwy J, Eder S, Denicolò S, Mayer…

Christof Simon

Love0

For the public & patients Industry & stakeholders

November 20, 2023

DC-ren GENERAL ASSEMBLY 2023

Members of the DC-ren consortium, convened for the meeting at the AC Hotel in Innsbruck,…

Christof Simon

Love0

Physicians & academics

November 17, 2023

Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.

Møller AL, Thöni S, Keller F, Sharifli S, Rasmussen DGK, Genovese F, Karsdal MA, Mayer…

Christof Simon

Love0

Physicians & academics

November 1, 2023

Candidate composite biomarker to inform drug treatments for diabetic kidney disease.

Jones RD, Abebe S, Distefano V, Mayer G, Poli I, Silvestri C, Slanzi D.Front Med…

Christof Simon

Love0

Physicians & academics

September 14, 2023

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.

Jaimes Campos MA, Andújar I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C,…

Christof Simon

Love0

© 2020 by the DC-ren consortium